European ADHD Study Delivers Positive Results
Filed with ASX · · 5 pages · English
Summary by 6ix AI
Blinklab Limited has announced positive results from its European ADHD study, which supports the expansion of its diagnostic platform beyond autism. The findings will guide the company towards regulatory studies in the US, following a similar path taken for its autism product. This announcement also indicates a collaborative effort with Mental Care Group, completed at no cost to Blinklab, showcasing the effectiveness of its research model.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Blinklab
- 2026 Annual Report & Appendix 4E
- BlinkLab Secures A$17.5M to Launch Autism Diagnostic Aid
- BlinkLab Launches Pivotal US FDA Trial for AI Smartphone Autism Diagnostic
- Validation Program Commences-FDA 510(k) - First Participant
- Morocco's Nationwide Government-Funded Autism Screening
Later from Blinklab
All Blinklab news releasesFollow Blinklab into a list and get an email when it puts out news.
Follow Blinklab